EGFR and non-small cell lung carcinoma: The ddPCR results validated the finding from NGS that the NSCLC patient carries both EGFR L858R and T790M mutations, indicating the high-throughput and sensitive advantages of NGS analysis of ctDNAs over ARMS analysis of ppDNAs.